This inventor holds 4 USPTO granted patents. Top assignees: Solvay Pharmaceuticals, Gmbh, Solvay Pharmaceuticals, B.v.. Active years: 2006-2008.
Company Filing History:
Years Active: 2006-2008
Title: Innovations and Contributions of Inventor Jakob Venema
Introduction
Jakob Venema is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of G-protein coupled receptors. With a total of 4 patents to his name, Venema's work has implications for both scientific research and potential therapeutic applications.
Latest Patents
Venema's latest patents include groundbreaking inventions related to G-protein coupled receptors. One of his notable patents is titled "Binding assay employing IGS4, a human G-protein coupled neuromedin receptor." This invention focuses on novel identified polynucleotides and polypeptides, detailing their production and use. The invention also explores methods for inhibiting or activating the action of these polynucleotides and polypeptides, as well as screening compounds that can act as agonists or antagonists of the IGS family. Another significant patent is "Polynucleotides and expression system of a novel human G-protein coupled receptor," which similarly addresses the G-protein coupled receptor family, referred to as the IGS4-family. Both patents highlight high-affinity binding to neuropeptides known as neuromedin U.
Career Highlights
Throughout his career, Jakob Venema has worked with prominent companies in the pharmaceutical industry, including Solvay Pharmaceuticals GmbH and Solvay Pharmaceuticals B.V. His experience in these organizations has contributed to his expertise in the field of biotechnology and receptor research.
Collaborations
Venema has collaborated with notable professionals in his field, including Willy Deleersnijder and Guy Nys. These collaborations have likely enriched his research and contributed to the advancements in his patented technologies.
Conclusion
Jakob Venema's innovative work in the realm of G-protein coupled receptors showcases his significant contributions to biotechnology. His patents not only advance scientific understanding but also hold promise for future therapeutic developments.